Physician profile
Jayeshkumar A Patel
NPI 1730195793
$12,095.72
in general payments reported to CMS, 2019-2025
18 companies · $1,836 in 2025
The $1,836 reported for 2025 was more than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $631 · 2020: $565 · 2021: $351 · 2022: $919 · 2023: $7,001 · 2024: $794 · 2025: $1,836.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $4,040 · Travel and Lodging: $3,134 · Food and Beverage: $2,457.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $4,040.00 |
| Travel and Lodging | $3,134.09 |
| Food and Beverage | $2,456.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $3,271.40 | 2020-2025 | Impella |
| Ethicon INC. | $2,618.01 | 2023-2024 | Vistaseal, Echelon; Endopath |
| Transmedics, INC. | $2,325.39 | 2023 | Organ Care System |
| Medical Device Business Services, INC. | $1,010.00 | 2023 | Echelon; Endopath |
| Abbott Laboratories | $865.13 | 2020-2024 | Thoratec Heartmate 3 Lvas Implant Kit, Mitraclip |
| Ethicon US, LLC | $612.83 | 2019-2023 | Surgicel Nu-Knit, Vistaseal |
| Edwards Lifesciences Corporation | $357.42 | 2019-2022 | |
| Baxter Healthcare | $282.00 | 2019 | |
| Impulse Dynamics (USA) INC. | $181.11 | 2022 | |
| Atricure, INC. | $178.27 | 2025 | Atricure Cryoice Cryosphere Cryoablation System |
| Boston Scientific Corporation | $108.44 | 2019 | |
| Masimo Corporation | $89.97 | 2023 | Set and Rainbow Set, Na |
| Livanova USA, INC. | $65.86 | 2019 | |
| Zimmer Biomet Holdings, INC. | $34.19 | 2022 | |
| Medtronic Vascular, INC. | $33.56 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cvrx, INC. | $22.54 | 2025 | Barostim Neo System |
| Actelion Pharmaceuticals US, INC. | $22.28 | 2021 | |
| Smith+Nephew, INC. | $17.32 | 2025 | Versajet, Oasis, "Acticoat 4"" X 4""" |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jayeshkumar Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.